Geron (GERN) Price to Earnings (2010 - 2026)
Geron's (GERN) quarterly Price to Earnings came in at 49.33 in Q2 2026, up 10.54% year-over-year from 44.62 in Q2 2025, and up 81.54% quarter-over-quarter from 267.2 in Q1 2026.
Analysis
Geron (GERN) Price to Earnings (2010 - 2026) Analysis & Trends
Geron has disclosed Price to Earnings across 17 years of filings, most recently posting 49.33 for Q2 2026.
- In Q2 2026, Price to Earnings rose 10.54% year-over-year to 49.33; the TTM figure through Jun 2026 stood at 12.22 (down 16.88% YoY), while the FY2025 annual figure was 10.16, up 18.29% from the prior year.
- Price to Earnings came in at 49.33 for Q2 2026 at Geron, up from 267.2 in the prior quarter.
- In the past five years, Price to Earnings ranged from a high of 16.72 in Q1 2022 to a low of 267.2 in Q1 2026.
- Average Price to Earnings over 5 years is 53.34, with a median of 34.76 recorded in 2023.
- Year-over-year, Price to Earnings soared 67.75% in 2025 and slumped 421.16% in 2026.
- Over 5 years, Price to Earnings stood at 22.11 in 2022, then advanced by 0.01% to 22.1 in 2023, then plunged by 311.54% to 90.97 in 2024, then surged by 67.75% to 29.33 in 2025, then sank by 68.16% to 49.33 in 2026.
- Per Business Quant data, the three most recent Price to Earnings figures were 49.33 in Q2 2026, 267.2 in Q1 2026, and 29.33 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.33 |
| Mar 31, 2026 | -267.20 |
| Dec 31, 2025 | -29.33 |
| Sep 30, 2025 | -47.88 |
| Jun 30, 2025 | -55.14 |
| Mar 31, 2025 | -51.27 |
| Dec 31, 2024 | -90.97 |
| Sep 30, 2024 | -104.02 |
| Jun 30, 2024 | -37.97 |
| Mar 31, 2024 | -35.38 |
| Dec 31, 2023 | -22.10 |
| Sep 30, 2023 | -25.75 |
| Jun 30, 2023 | -34.14 |
| Mar 31, 2023 | -28.93 |
| Dec 31, 2022 | -22.11 |
| Sep 30, 2022 | -21.80 |
| Jun 30, 2022 | -20.04 |
| Mar 31, 2022 | -16.72 |
| Dec 31, 2021 | -12.34 |
| Sep 30, 2021 | -16.57 |